Acute and chronic effects of metabolic acidosis on renal function and structure
Emerging evidence suggests that chronic metabolic acidosis (CMA) may have significant implications in terms of worsening renal disease in CKD patients, but the effect of CMA on renal function and structure has not been fully elucidated.
We studied the acute and chronic consequences of an acid load (AL) on glomerular filtration rate (GFR) and renal histology in C57BL/6 mice. FITC-inulin clearance was performed at several time points; markers of renal fibrosis were studied at mRNA and protein levels; finally, kidney expression of candidate molecules triggering changes in renal function was studied.
Glomerular hyperfiltration occurred within 1–3 days from AL; after 1 week, the GFR returned to baseline and then declined progressively within 15–21 days. The GFR decline was accompanied by the onset of renal fibrosis, as shown by Masson trichrome staining. Markers of renal fibrosis, namely α-smooth muscle actin and collagen-1, increased after 1 day of acid loading in both mRNA and protein levels and remained higher than baseline for up to 21 days. Well-known mediators of renal fibrosis, including transforming growth factor (TGF)-β and the intrarenal renin–angiotensin system (RAS) axis, were increased even before the decline of the GFR.
Acid load caused hyperfiltration acutely and a progressive decline of the GFR chronically; the evidence of renal fibrosis indicates that structural and not only functional renal changes occurred. The concomitant upregulation of TGF-β and intrarenal RAS axis indicates that those factors may be potentially involved in the progression of kidney disease in this setting.
KeywordsMetabolic acidosis Renal fibrosis TGF-β RAS axis
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All applicable international, national and institutional guidelines for the care and use of animals were followed. This article does not contain any studies with humans participants.
For this type of study formal consent form is not required.
- 2.Gaggi M, Sliber C, Sunder-Plassmann G (2014) Effect of oral alkali supplementation on progression of chronic kidney disease. Curr Hypertens Rev 10(2):112–120Google Scholar
- 5.Iervolino A, Trepiccione F, Petrillo F, Spagnuolo M, Scarfò M, Frezzetti D, De Vita G, De Felice M, Capasso G (2015) Selective dicer suppression in the kidney alters GSK3β/β-catenin pathways promoting a glomerulocystic disease. PLoS ONE 10(3):e0119142. https://doi.org/10.1371/journal.pone.0119142 CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Capobianco V, Caterino M, Iaffaldano L, Nardelli C, Sirico A, Del Vecchio L, Martinelli P, Pastore L, Pucci P, Sacchetti L (2016) Proteome analysis of humanamniotic mesenchymal stem cells (hA-MSCs) reveals impaired antioxidantability, cytoskeleton and metabolic functionality in maternal obesity. Sci Rep 29(6):25270. https://doi.org/10.1038/srep25270 CrossRefGoogle Scholar
- 11.Laghmani K, Preisig PA, Alpern RJ (2002) The role of endothelin in proximal tubule proton secretion and the adaptation to a chronicmetabolic acidosis. J Nephrol 15(Suppl 5):S75–S87Google Scholar
- 29.Perna AF, Di Nunzio A, Amoresano A, Pane F, Fontanarosa C, Pucci P, Vigorito C, Cirillo G, Zacchia M, Trepiccione F, Ingrosso D (2017) Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients. Biochimie 126:97–107. https://doi.org/10.1016/j.biochi.2016.04.018 CrossRefGoogle Scholar
- 30.Petrazzuolo O, Trepiccione F, Zacchia M, Capasso G (2010) Hypertension and renal calcium transport. J Nephrol 23(Suppl 16):S112-S117Google Scholar